The licensed indications for Wyeth Laboratories's Zoton (lansoprazole) capsules and suspension have been extended. Zoton is now additionally indicated for the "prophylaxis of NSAID-associated benign gastric and duodenal ulcers and relief of symptoms in patients requiring continued NSAID treatment."